Top compounds associated with response to TBC1D10A


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.062 0.05
mRNA canertinib CTRPv2 pan-cancer AAC 0.075 0.05
mRNA JW-480 CTRPv2 pan-cancer AAC 0.078 0.05
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.077 0.05
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.05
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.06
mRNA pac-1 CTRPv2 pan-cancer AAC -0.073 0.06
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.1 0.06
mRNA alisertib CTRPv2 pan-cancer AAC -0.063 0.06
mRNA niclosamide CTRPv2 pan-cancer AAC -0.072 0.06
Download CSV